CDEK
← All drugs Report issue

mistletoe

Botanicalexperimental

Mistletoe is the common name for obligate hemiparasitic plants in the order Santalales. They are attached to their host tree or shrub by a structure called the haustorium, through which they extract water and nutrients from the host plant. There are hundreds of species which mostly live in tropical regions. — Wikipedia

Clinical trial activity

17 trials · 28 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
9
Phase 3
3
Phase 4
3

Earliest trial started Aug 1, 2000 (NCT00006354)

Timeline

2000s

  1. Jan 1, 2000

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2001

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • abnobaviscum
  • loranthace
  • mistletoe
  • mistletoe
  • mistletoe extract

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06920810Phase 4Mar 19, 2025Ilsan Hospital
NCT06408688Phase 4Jun 30, 2024University of Basel
NCT05726383Phase 2Dec 15, 2023Hackensack University Medical Center, University of Texas at Houston
NCT04376931Phase 1/Phase 2 (Phase 2)Jul 1, 2020Emek Medical Center, Technion University
NCT03051477Phase 1Mar 1, 2017Johns Hopkins University
NCT02948309Phase 3Jun 1, 2016Cancerforskningsfonden i Norrland, Dagmar Ferbs Minnesfond, Ekhagastiftelsen, Karolinska Institute, Regional Cancer Centre Stockholm Gotland, Signe & Ane Gyllenbergs Stiftelse, University of Witten/Herdecke
NCT02106572Phase 3Feb 1, 2015Abnoba, University of Duisburg-Essen
NCT02191540Phase 3Jan 1, 2011Abnoba, Busan University, Chonnam National University, FORSCHUNGSINSTITUT HAVELHOHE, University of Ulsan
NCT01378702Phase 1Jan 1, 2008University of Freiburg
NCT00516022Phase 2Apr 1, 2007Technion University, Weleda AG
NCT01401075Phase 4Mar 1, 2006Abnoba, University of Ulsan
NCT02007005Phase 1/Phase 2 (Phase 2)Jan 1, 2004Abnoba, University of Duisburg-Essen
NCT00052325Phase 2Oct 1, 2002National Cancer Institute (NCI), Thomas Jefferson University
NCT00049608Phase 1Jul 1, 2002National Cancer Institute (NCI), National Center for Complementary and Integrative Health (NCCIH)
NCT00079794Phase 2Sep 1, 2001National Center for Complementary and Integrative Health (NCCIH), Thomas Jefferson University
NCT00006477Phase 1Sep 1, 2000European Organisation for Research and Treatment of Cancer, University of Oslo
NCT00006354Phase 1Aug 1, 2000European Organisation for Research and Treatment of Cancer, Gottfried Wilhelm Leibniz Universität Hannover
Showing 17 of 17 trials
Page 1 / 1

Organizations

Research & Development (28)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AbnobaFor profit4432004
European Organisation for Research and Treatment of CancerAcademic/Hospital2212000
National Cancer Institute (NCI)Government2022002
National Center for Complementary and Integrative Health (NCCIH)Government2222001
Technion UniversityAcademic/Hospital2112007
Thomas Jefferson UniversityAcademic/Hospital2112001
University of Duisburg-EssenAcademic/Hospital2022004
University of UlsanAcademic/Hospital2022006
Busan UniversityAcademic/Hospital1012011
Cancerforskningsfonden i NorrlandAcademic/Hospital1012016
Chonnam National UniversityAcademic/Hospital1012011
Dagmar Ferbs MinnesfondAcademic/Hospital1012016
EkhagastiftelsenAcademic/Hospital1012016
Emek Medical CenterAcademic/Hospital1112020
FORSCHUNGSINSTITUT HAVELHOHEAcademic/Hospital1012011
Gottfried Wilhelm Leibniz Universität HannoverAcademic/Hospital1012000
Hackensack University Medical CenterAcademic/Hospital1112023
Ilsan HospitalAcademic/Hospital1112025
Johns Hopkins UniversityAcademic/Hospital1112017
Karolinska InstituteAcademic/Hospital1112016
28 organizations
Page 1 / 2